Patrick (“Pat”) Ritschel is an entrepreneur and life science investor with over 20 years of experience in business management, business development and technology licensing. Mr. Ritschel spent his early career with Monsanto Enviro-Chem Systems, Inc. in St. Louis and Hong Kong. While in Hong Kong, he joined members of management to acquire the Enviro-Chem subsidiary from Monsanto. Upon the sale of the business to DuPont Clean Technologies, he returned to the U.S. as Director of Business Development for DuPont. Mr. Ritschel was an angel investor and served multiple roles during the formation of Bamboo Therapeutics (later sold to Pfizer), and serves on the Board of Directors of the Friedreich’s Ataxia Research Alliance (FARA).
Mr. Ritschel holds a B.S. in Mechanical Engineering from the University of Illinois Urbana-Champaign, cum laude, and an M.B.A. from Washington University in St. Louis.